Lopez Ibor

Nouveau
32 années d'expérience
accréditations:
Lieu : Espagne, Madrid
Clinique :Hospital Universitario HM Montepríncipe
Avec plus de 20 ans d'expérience, le Dr Lopez Ibor dirige l'unité d'hématologie et d'oncologie pédiatriques de l'hôpital HM Montepríncipe.
- Se spécialiser dans les tumeurs osseuses et cérébrales pédiatriques
- Se former en hématologie et oncologie pédiatriques à l'Université du Maryland
- Auteur de nombreuses publications scientifiques
- Diriger précédemment la même unité à l'Hospital Universitario Clínica San Rafael
Lire la suite

Nouveau

Visite du médecin

Prix sur demande

Bookimed Insights : Meilleurs spécialistes d'adénocarcinome en Espagne (2026)

Bookimed a coordonné 8 demandes pour le traitement de Adénocarcinome en Espagne, en collaboration avec 1 spécialistes. Les médecins de ce tableau se distinguent régulièrement par leurs qualifications et leur expertise à répondre aux besoins spécifiques des patients. Toutes les informations proviennent de cas réels de patients et d'offres de traitement créées par nos cliniques partenaires.

Classement	Médecin	expérience	Bon choix pour	Ce qui les distingue	Clinique et emplacement	Consultation
#1	Lopez Ibor	32 années d'expérience	Tumeurs osseuses et cérébrales pédiatriques	Dirige une unité d'oncologie pédiatrique dédiée, spécialisée dans les tumeurs solides. Formé aux États-Unis et auteur de nombreuses publications sur les cancers de l'enfant.	Hospital Universitario HM Montepríncipe Espagne	Prix sur demande

FAQ

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

What are the primary treatment options for adenocarcinoma in Spain?

Spain offers multidisciplinary adenocarcinoma treatments through surgery, high-precision radiation, and oncology protocols within JCI-accredited centers. Major options include robotic-assisted surgery for resectable tumors and advanced Proteus ONE proton therapy. Specialized approaches like HIPEC and personalized targeted therapies are standard at leading academic hospitals.

Surgical robotics: Surgeons use the da Vinci system for precise prostate and gastrointestinal procedures.
Advanced radiotherapy: Proton therapy at specialized centers scales doses to minimize surrounding tissue damage.
Intraperitoneal chemotherapy: HIPEC treats metastatic abdominal adenocarcinomas immediately following tumor debulking surgery.
Targeted oncology: Genetic testing identifies HER2 or KRAS mutations to guide immunotherapy drug selection.

Bookimed Expert Insight: Spain’s oncology market shows a clear focus on high-volume efficiency. Hospital Universitario HM Madrid manages over 2.3 million outpatients annually. This massive case volume allows specialized centers like the Proton Therapy Centre Quironsalud to accumulate expertise quickly. For example, their specialists have already managed over 900 cases with the Proteus ONE system since 2019.

Patient Consensus: Patients emphasize the need for a second opinion before surgery to confirm tumor staging. Many note that choosing between surgery-first or chemotherapy-first protocols significantly impacts their long-term quality of life.

Which clinics are considered leaders in adenocarcinoma care in Spain?

Spain hosts globally recognized oncology centers like Quironsalud Madrid and Centro Médico Teknon. These JCI-accredited facilities lead in adenocarcinoma care using robotic surgery and proton therapy. Top institutions often feature specialized units for lung, prostate, and colorectal cancers, ensuring high success rates for local and international patients.

Clinic credentials: Clinica Universidad de Navarra is the top-rated private hospital in Spain.
Advanced technology: Proton Therapy Centre Quironsalud offers Spain's first Proteus ONE proton system.
Specialized oncology: Hospital Quiron Barcelona partners with the world-renowned Baselga Institute of Oncology.
Patient capacity: HM Hospitales serve over 2.3 million outpatients with dedicated oncology centers.

Bookimed Expert Insight: Patient volume indicates clinic prestige and safety in Spain. HM Hospitales and Hospital HM Nou Delfos manage 400,000+ patients annually. High volume often correlates with better outcomes in complex surgeries. For example, Dr. Antonio Alcaraz at Hospital Quiron Barcelona performs advanced robotic procedures. These high-capacity centers typically offer more robust clinical trial access than smaller boutique clinics.

Patient Consensus: Patients emphasize finding clinics with integrated tumor boards for stage IV cases. Reliable pathology reviews and quick access to targeted therapies like immunotherapy are also highly valued.

Can international patients join clinical trials for adenocarcinoma in Spain?

International patients can join adenocarcinoma clinical trials in Spain. Success often depends on residency status and trial phase. Most public trials require European Union (EU) residency or a specific sponsor visa. Private networks like Quironsalud frequently facilitate access for non-EU participants through dedicated international departments.

Referral paths: EU patients use S2 forms. Non-EU patients must contact hospital trial units.
Financial rules: Study medications are free. Patients must self-fund all travel and local lodging.
Leading centers: Quironsalud Madrid and Clinica Universidad de Navarra actively recruit for advanced tumors.
Admission priority: Ethics boards often prioritize local residents. Pharma-sponsored private trials offer higher acceptance.

Bookimed Expert Insight: Quironsalud Madrid stands out for international trial seekers. Unlike many public facilities, it explicitly offers opportunities for patients to receive treatment for free by participating in clinical trials. This clinic is a strategic choice because it combines high-tech diagnostics with a specific administrative path for international trial enrollment.

Patient Consensus: Patients note that private bridges like Quironsalud are more successful at handling paperwork for international applicants. Many emphasize that you should prepare for a three-to-six-month stay to meet the strict trial follow-up requirements.

What documentation should I prepare before traveling to Spain for adenocarcinoma treatment?

To prepare for adenocarcinoma treatment in Spain, you must organize comprehensive medical records and legal documents. Ensure you have histological reports, digital DICOM imaging, and oncological summaries. Non-EU patients require a hospital invitation letter, specialized travel insurance, and proof of financial means for visa approval.

Medical reports: Provide detailed pathology, biopsy results, and prior treatment summaries.
Imaging data: Carry CT, MRI, and PET scans on digital media.
Certified translations: Translate all clinical documents into Spanish to prevent treatment delays.
Visa invitation: Secure an official hospital letter confirming treatment dates and acceptance.
Insurance coverage: Maintain a policy with 30,000 EUR minimum coverage including repatriation.

Bookimed Expert Insight: While many expect straightforward admissions, Spanish JCI-accredited centers like Clinica Universidad de Navarra or Hospital Quiron Barcelona often require a second histopathology revision. Our data shows that top researchers like Dr. Carme Ares may request original glass slides for specialized proton therapy planning. Sending these by courier before your flight can save up to 7 days during the diagnostic phase in Spain.

Patient Consensus: Patients note it is vital to carry a 3-month supply of ongoing medications in original packaging. They also emphasize that having notarized Spanish translations avoids the risk of customs officials seizing unlabeled oncology drugs.

Is proton therapy safer than standard radiotherapy for adenocarcinoma?

Proton therapy is safer than standard radiotherapy because it eliminates the exit dose of radiation. While X-rays pass through the body, proton beams stop at a specific depth. This protects healthy tissue and critical organs from collateral damage during adenocarcinoma treatment.

Targeted precision: Proton beams deliver the maximum dose directly into the tumor.
Reduced toxicity: Studies show an 11.5% severe side effect rate versus 27.6% for X-rays.
Organ preservation: Spares nearby organs like the heart, lungs, bladder, or rectum.
Secondary risk: Lower exit radiation significantly reduces the long-term risk of secondary cancers.

Bookimed Expert Insight: While Spain's first center, Proton Therapy Centre Quironsalud, uses the advanced Proteus ONE system, it is important to note that proton therapy is not always a faster treatment. For example, brain tumor packages involve a 25-day stay, while lung or esophageal cases require 45 to 60 days. This longer duration often reflects the complexity of cases where protons are chosen specifically to protect vital organs near the tumor site.

Patient Consensus: Patients note it is critical to compare dosimetry plans between protons and photons to see how much radiation is actually spared. Many emphasize that this technology is life-changing for preserving urinary and heart function compared to traditional methods.

What all-inclusive packages do Spanish hospitals offer to foreign adenocarcinoma patients?

Spanish hospitals offer specialized oncology bundles featuring advanced diagnostics and high-precision treatments for adenocarcinoma. These arrangements typically include personalized treatment planning through PET/CT scans and genomic profiling. Specialized protocols like Proteus ONE proton therapy and robotic surgery are common in JCI-accredited facilities.

Surgical bundles: Procedures like robotic prostatectomy may cost approximately $29,000.
Advanced diagnostics: Bundles often include tumor markers, 3D CT scans, and MRI scans.
Treatment technology: Proton therapy packages utilize Proteus ONE for lung or esophageal tumors.
Hospital stays: Surgical packages frequently include private rooms and all necessary medications.

Bookimed Expert Insight: Spanish oncology centers often differentiate their packages through extended hotel partnerships rather than hospital stays. For instance, proton therapy protocols at Quironsalud include up to 45–60 days of hotel stay coordination. This is because these advanced treatments are outpatient-based. This structure allows patients to recover in a more comfortable environment while remaining close to the clinic.

Patient Consensus: Patients note that having a dedicated individual chamber during surgical recovery makes a significant difference. They also appreciate receiving comprehensive medical reports in English to share with their doctors at home.

Les Meilleurs doctors pour le traitement d'adénocarcinome à Madrid - TOP-1 des médecins

Obtenez des devis de 3 meilleurs spécialistes en Espagne